Tarsus Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US87650L1035

SecurityTARS / Tarsus Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership163,997 shares
Latest Disclosed Value $ 11,504,389
Citadel Advisors Llc ownership in TARS / Tarsus Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 163,997 shares of Tarsus Pharmaceuticals, Inc. (US:TARS) valued at $11,504,390 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of Tarsus Pharmaceuticals, Inc.. The current value of the position is $9,721,742 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (TARS) in the form of stock options. The firm currently holds call options representing 15,900 of underlying shares valued at $1,115,385 USD and put options representing 3,200 of underlying shares valued at $224,480 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TARS / Tarsus Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TARSUS PHARMACEUTICALS COM 87650L103 163,997 163,997 11,504 0.0016
2026-02-17 2025-12-31 13F TARSUS PHARMACEUTICALS COM 87650L103 0 -43,281 -100.00 0 -100.00
2025-11-14 2025-09-30 13F TARSUS PHARMACEUTICALS COM 87650L103 43,281 -185,965 -81.12 2,572 -72.30 0.0004
2025-08-14 2025-06-30 13F TARSUS PHARMACEUTICALS COM 87650L103 229,246 -763,396 -76.91 9,287 -81.79 0.0016
2025-05-15 2025-03-31 13F TARSUS PHARMACEUTICALS COM 87650L103 992,642 913,301 1,151.11 50,992 1,060.76 0.0097
2025-02-14 2024-12-31 13F TARSUS PHARMACEUTICALS COM 87650L103 79,341 -305,126 -79.36 4,393 -65.26 0.0008
2024-11-14 2024-09-30 13F TARSUS PHARMACEUTICALS COM 87650L103 384,467 176,978 85.30 12,645 124.24 0.0024
2024-08-14 2024-06-30 13F TARSUS PHARMACEUTICALS COM 87650L103 207,489 -11,789 -5.38 5,640 -29.25 0.0011
2024-05-15 2024-03-31 13F TARSUS PHARMACEUTICALS COM 87650L103 219,278 176,241 409.51 7,971 815.04 0.0015
2024-02-14 2023-12-31 13F TARSUS PHARMACEUTICALS COM 87650L103 43,037 37,173 633.92 871 737.50 0.0002
2023-11-14 2023-09-30 13F TARSUS PHARMACEUTICALS COM 87650L103 5,864 -131,753 -95.74 104 -95.82 0.0000
2023-08-14 2023-06-30 13F TARSUS PHARMACEUTICALS COM 87650L103 137,617 85,361 163.35 2,487 278.96 0.0005
2023-05-15 2023-03-31 13F TARSUS PHARMACEUTICALS COM 87650L103 52,256 31,289 149.23 657 113.68 0.0001
2023-02-14 2022-12-31 13F TARSUS PHARMACEUTICALS COM 87650L103 20,967 20,967 307 0.0001
2022-11-14 2022-09-30 13F TARSUS PHARMACEUTICALS COM 87650L103 0 -20,873 -100.00 0 -100.00
2022-08-15 2022-06-30 13F TARSUS PHARMACEUTICALS COM 87650L103 20,873 -4,228 -16.84 305 -27.73 0.0001
2022-05-16 2022-03-31 13F TARSUS PHARMACEUTICALS COM 87650L103 25,101 25,101 422 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TARSUS PHARMACEUTICALS COM Call 15,900 1,115 n/a n/a n/a
2026-02-17 2025-12-31 13F TARSUS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F TARSUS PHARMACEUTICALS COM Call 6,600 -15.38 392 24.44 n/a n/a n/a
2025-08-14 2025-06-30 13F TARSUS PHARMACEUTICALS COM Call 7,800 -46.58 316 -58.00 n/a n/a n/a
2025-05-15 2025-03-31 13F TARSUS PHARMACEUTICALS COM Call 14,600 17.74 750 9.33 n/a n/a n/a
2025-02-14 2024-12-31 13F TARSUS PHARMACEUTICALS COM Call 12,400 -16.22 687 41.15 n/a n/a n/a
2024-11-14 2024-09-30 13F TARSUS PHARMACEUTICALS COM Call 14,800 114.49 487 159.89 n/a n/a n/a
2024-08-14 2024-06-30 13F TARSUS PHARMACEUTICALS COM Call 6,900 -42.98 188 -57.40 n/a n/a n/a
2024-05-15 2024-03-31 13F TARSUS PHARMACEUTICALS COM Call 12,100 -4.72 440 70.82 n/a n/a n/a
2024-02-14 2023-12-31 13F TARSUS PHARMACEUTICALS COM Call 12,700 6.72 257 21.80 n/a n/a n/a
2023-11-14 2023-09-30 13F TARSUS PHARMACEUTICALS COM Call 11,900 340.74 211 339.58 n/a n/a n/a
2023-08-14 2023-06-30 13F TARSUS PHARMACEUTICALS COM Call 2,700 440.00 49 700.00 n/a n/a n/a
2023-05-15 2023-03-31 13F TARSUS PHARMACEUTICALS COM Call 500 -98.73 6 -98.96 n/a n/a n/a
2023-02-14 2022-12-31 13F TARSUS PHARMACEUTICALS COM Call 39,400 1.29 578 -13.36 n/a n/a n/a
2022-11-14 2022-09-30 13F TARSUS PHARMACEUTICALS COM Call 38,900 3.73 666 21.53 n/a n/a n/a
2022-08-15 2022-06-30 13F TARSUS PHARMACEUTICALS COM Call 37,500 548 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F TARSUS PHARMACEUTICALS COM Put 3,200 224 n/a n/a n/a
2025-08-14 2025-06-30 13F TARSUS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F TARSUS PHARMACEUTICALS COM Put 7,600 -74.15 390 -76.03 n/a n/a n/a
2025-02-14 2024-12-31 13F TARSUS PHARMACEUTICALS COM Put 29,400 617.07 1,628 1,114.18 n/a n/a n/a
2024-11-14 2024-09-30 13F TARSUS PHARMACEUTICALS COM Put 4,100 141.18 135 191.30 n/a n/a n/a
2024-08-14 2024-06-30 13F TARSUS PHARMACEUTICALS COM Put 1,700 -92.38 46 -94.32 n/a n/a n/a
2024-05-15 2024-03-31 13F TARSUS PHARMACEUTICALS COM Put 22,300 209.72 811 458.62 n/a n/a n/a
2024-02-14 2023-12-31 13F TARSUS PHARMACEUTICALS COM Put 7,200 3,500.00 146 4,733.33 n/a n/a n/a
2023-11-14 2023-09-30 13F TARSUS PHARMACEUTICALS COM Put 200 -94.59 4 -95.45 n/a n/a n/a
2023-08-14 2023-06-30 13F TARSUS PHARMACEUTICALS COM Put 3,700 54.17 67 120.00 n/a n/a n/a
2023-05-15 2023-03-31 13F TARSUS PHARMACEUTICALS COM Put 2,400 1,100.00 30 1,400.00 n/a n/a n/a
2023-02-14 2022-12-31 13F TARSUS PHARMACEUTICALS COM Put 200 3 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.